1. Home
  2. AAT vs MESO Comparison

AAT vs MESO Comparison

Compare AAT & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAT
  • MESO
  • Stock Information
  • Founded
  • AAT 1967
  • MESO 2004
  • Country
  • AAT United States
  • MESO Australia
  • Employees
  • AAT N/A
  • MESO N/A
  • Industry
  • AAT Real Estate Investment Trusts
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AAT Real Estate
  • MESO Health Care
  • Exchange
  • AAT Nasdaq
  • MESO Nasdaq
  • Market Cap
  • AAT 1.2B
  • MESO 1.3B
  • IPO Year
  • AAT 2011
  • MESO N/A
  • Fundamental
  • Price
  • AAT $20.12
  • MESO $15.89
  • Analyst Decision
  • AAT Hold
  • MESO Buy
  • Analyst Count
  • AAT 2
  • MESO 4
  • Target Price
  • AAT $21.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • AAT 474.2K
  • MESO 332.3K
  • Earning Date
  • AAT 07-29-2025
  • MESO 08-28-2025
  • Dividend Yield
  • AAT 6.82%
  • MESO N/A
  • EPS Growth
  • AAT 49.17
  • MESO N/A
  • EPS
  • AAT 1.33
  • MESO N/A
  • Revenue
  • AAT $451,281,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • AAT N/A
  • MESO $178.09
  • Revenue Next Year
  • AAT $2.09
  • MESO $305.06
  • P/E Ratio
  • AAT $15.03
  • MESO N/A
  • Revenue Growth
  • AAT 2.65
  • MESO N/A
  • 52 Week Low
  • AAT $16.69
  • MESO $5.78
  • 52 Week High
  • AAT $29.15
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • AAT 48.23
  • MESO 67.42
  • Support Level
  • AAT $19.92
  • MESO $14.45
  • Resistance Level
  • AAT $20.43
  • MESO $17.63
  • Average True Range (ATR)
  • AAT 0.41
  • MESO 0.54
  • MACD
  • AAT -0.05
  • MESO 0.43
  • Stochastic Oscillator
  • AAT 13.51
  • MESO 75.51

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: